199 related articles for article (PubMed ID: 27878305)
1. miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2.
Cao H; Liu Z; Wang R; Zhang X; Yi W; Nie G; Yu Y; Wang G; Zhu M
Oncol Rep; 2017 Jan; 37(1):147-154. PubMed ID: 27878305
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
Xu X; Wu J; Li S; Hu Z; Xu X; Zhu Y; Liang Z; Wang X; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
Mol Cancer; 2014 May; 13():109. PubMed ID: 24886554
[TBL] [Abstract][Full Text] [Related]
6. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma.
Jiao D; Wu M; Ji L; Liu F; Liu Y
Oncol Res; 2018 Mar; 26(2):249-259. PubMed ID: 28550686
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
Yamada Y; Hidaka H; Seki N; Yoshino H; Yamasaki T; Itesako T; Nakagawa M; Enokida H
Cancer Sci; 2013 Mar; 104(3):304-12. PubMed ID: 23176581
[TBL] [Abstract][Full Text] [Related]
9. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
Ye ZH; Gui DW
Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
Yamasaki T; Seki N; Yoshino H; Itesako T; Yamada Y; Tatarano S; Hidaka H; Yonezawa T; Nakagawa M; Enokida H
Cancer Sci; 2013 Nov; 104(11):1411-9. PubMed ID: 23889809
[TBL] [Abstract][Full Text] [Related]
11. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
[TBL] [Abstract][Full Text] [Related]
12. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
[TBL] [Abstract][Full Text] [Related]
13. MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.
Pan Y; Hu J; Ma J; Qi X; Zhou H; Miao X; Zheng W; Jia L
Mol Carcinog; 2018 Aug; 57(8):1067-1077. PubMed ID: 29667779
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
[TBL] [Abstract][Full Text] [Related]
16. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
[TBL] [Abstract][Full Text] [Related]
17. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
18. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma.
Zhang S; Zhang D; Yi C; Wang Y; Wang H; Wang J
Oncol Rep; 2016 Jan; 35(1):559-67. PubMed ID: 26499759
[TBL] [Abstract][Full Text] [Related]
20. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
[No Abstract] [Full Text] [Related]
[Next] [New Search]